DFB Pharmaceuticals
Practical innovations for life

Phyton Biotech

API Development and Manufacturing via Plant Cell Fermentation.


Global Leaders in Plant Cell Fermentation Technology

DFB owns and operates Phyton Biotech®

  • The world’s first and only company to harness plant cell fermentation (PCF®) technology for development and scale up of plant-derived active ingredients

  • The world’s only company to commercially produce paclitaxel and docetaxel API via PCF®

  • Among the world’s largest global suppliers of high-quality paclitaxel and docetaxel API

  • Only paclitaxel and docetaxel API supplier in the world not relying on yew tree plantation-derived 10-DAB decreasing risk of drug shortage and offering unparalleled environmental responsibility

  • Development services and commercialization of plant-derived actives via PCF® in pharmaceutical, nutraceutical, and related industries

  • Recombinant development capability

visit phyton biotech >